LONDON: A leading scientist behind the University of Oxford’s potential COVID-19 vaccine said on Wednesday the team has seen the right sort of immune response in trials, which have entered the Phase III clinical stage.
Speaking at a parliamentary hearing, Sarah Gilbert, professor of vaccinology at the university, said the trial has enrolled 8,000 volunteers for the Phase III of its trial into the vaccine, AZD1222, which was licensed to AstraZeneca.
She said she couldn’t give a timeline for when the vaccine might be ready as it depends on the results of the trial.
![]()
Oxford University has seen ‘right sort of immune response’ in potential COVID-19 vaccine trial
Short Url
https://arab.news/5mkf7
Oxford University has seen ‘right sort of immune response’ in potential COVID-19 vaccine trial
- Gilbert said she couldn’t give a timeline for when the vaccine might be ready as it depends on the results of the trial
Hong Kong plans to buy homes devastated in deadly high-rise fire
HONG KONG: Hong Kong proposes to spend about HK$4 billion ($512 million) to buy out the owners of homes in a high-rise housing complex ravaged by a massive fire that killed more than 160 in November, authorities said on Saturday.
The prices offered will be HK$8,000 per sq. ft. without a land premium payment, and HK$10,500 per sq. ft for those receiving such a payment, officials in the Asian financial hub told a media briefing.
“We believe the proposed price is sufficient for the affected residents to relocate and secure long-term housing,” said Wong Wai-lun, Hong Kong’s deputy financial secretary.
The government also offered an apartment exchange program for the 4,600 affected tenants, who lived in nearly 2,000 housing units at the complex, Wang Fuk Court.
The total outlay, estimated at HK$6.8 billion, will drop by HK$2.8 billion from a contribution by a relief fund, and could go lower still after insurance compensation in factored in, the officials said. ($1=7.8148 Hong Kong dollars)
Latest updates
Recommended
© 2026 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.